Home > Healthcare > Biotechnology > Biopharma > Continuous Bioprocessing Market

Continuous Bioprocessing Market Trends

Report ID: GMI8350
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Continuous Bioprocessing Market Trends

Biopharmaceutical companies are increasingly adopting continuous manufacturing approaches to improve efficiency, reduce costs, and enhance product quality. Continuous bioprocessing offer advantages such as higher productivity, reduced footprint, and enhanced process control, driving its adoption across the industry.
Furthermore, single-use technologies are becoming increasingly integrated into continuous bioprocessing workflows. Single-use bioreactors, filtration systems, and other disposable components offer flexibility, scalability, and reduced risk of cross-contamination, making them well-suited for continuous manufacturing operations. Owing to these advantages, the market is expected to witness remarkable growth in coming years.

However, implementing continuous bioprocessing systems requires significant upfront investment in equipment, facility modifications, and training, which can be a barrier for some companies, particularly startups and smaller manufacturers.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of continuous bioprocessing was reached USD 207.6 million in revenue in 2023 and is set to expand at 22.1% CAGR from 2024 to 2032, driven by the increasing demand for biopharmaceuticals, and advancements in continuous bioprocessing technologies.

Continuous bioprocessing market from the instruments segment accounted for 65.7% revenue share in 2023 and is estimated to witness high demand till 2032 due to its indispensable role in enabling efficient, automated, and quality-assured biopharmaceutical manufacturing processes.

North America continuous bioprocessing market size is likely to cross USD 438.2 million by 2032 as this region boasts of a robust ecosystem of research institutions, academic centers, and biotechnology clusters that foster innovation in bioprocessing technologies.

Some of the top companies engaged in the continuous bioprocessing industry are 3M Company, Bionet, Danaher Corporation (Pall Corporation), Eppendorf SE, FUJIFILM HOLDINGS CORPORATION, Merck KGaA, Repligen Corporation, Sartorius AG, Thermo Fisher Scientific Inc., and WuXi Biologics.